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Case report
A 15-year-old boy was referred due to gynecomastia and short stature. He was 
overweight and showed the knuckle-dimple sign on the left hand, a short fourth 
toe on the left foot, and male external genitalia with a small phallus. His levels of 
estradiol and follicle-stimulating hormone were increased, and his testosterone 
concentration was normal. Other hormonal tests were within the normal range. 
Radiographs showed short fourth and fifth metacarpals and fourth metatarsal 
bones. The karyotype was reported as 46,X,+mar, and the marker chromosome was 
shown to originate from the Y chromosome, which was identified by fluorescence 
in situ hybridization. Polymerase chain reaction and direct sequencing were 
used to clarify the deleted loci of the Y chromosome by making use of Y-specific 
sequence-tagged sites (STSs). The sex-determining region Y and centromere were 
verified, and there were microdeletions on the long arm of the Y chromosome. 
The azoospermia factor (AZF) b region was partially deleted, and AZFa and AZFc 
were completely deleted. Two STS probes of sY143 and the Y chromosome RNA 
recognition motif in AZFb showed positive signals corresponding to Yq11.223. The 
karyotype of the patient was interpreted as 46,X,der(Y)del(Y)(q11.21q11.222)del(Y)
(q11.23qter). Herein, we report a rare case of a boy presenting with gynecomastia 
and short stature with 46, X, +mar, which originated from the Y chromosome, which 
was identified to have Yq microdeletions.    
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Gonadal differentiations arise from the sex chromosome determined at the beginning 
of gestation1). The existence of the Y chromosome plays a key role in the development of 
fetal gonads into the status of male sex determination, and is essential for spermatogenesis. 
In addition, the sex-determining region Y (SRY) is a well-known gene as one of the 
testis-determining factors located in the distal proximal region of the short arm of the Y 
chromosome2). Structural aberrations of the Y chromosome are reported in approximately 
less than 1% of newborn male babies. They appear at a breakage point and include various 
types of abnormalities, such as deletion, duplication, translocation, ring chromosomes, and 
isodicentricchromosomes3). The karyotype of the 46,X,+mar is one example of males having 
testicles without the normal structural Y chromosome in their non-mosaic karyotypes, which 
is rarely reported (Table 1)2,4,5).
A marker chromosome (mar) is a structurally abnormal chromosome that has no part 
that can be identified via conventional cytogenetic karyotype analysis6). The incidence of 
marker chromosomes in the perinatal period varies from 4%–15%6) and 7.9% in the referred 
population7). The importance of a marker chromosome depends on what genetic information 
and materials are preserved within it. It is critical to clarify the characteristics and origin of the 
marker chromosome because they are related to the phenotype and pathologic phenomenon.
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When a sex chromosome is not described in a conventional 
karyotype-carrying marker chromosome, it is generally 
assumed to be sex chromosome component within the marker 
chromosome. In this case, the fluorescence in situ hybridization 
(FISH) technique is conducted on a preferential basis to verify 
the sex chromosome.
Twenty-seven genes have been confirmed in the Y chromo-
some. Nine genes are located in the short arm, and 18 genes 
are in the long arm of the Y chromosome8). Deletions on 
Yq are related to growth alterations, skeletal development, 
spermatogenesis, and fertility. Therefore, cytogenetic molecular 
techniques are required to clarify the genetic and clinical 
characteristics of the marker chromosome.
Herein, we report a boy presenting gynecomastia and short 
stature carrying 46,X,+mar, which originated from the Y 
chromosome, and microdeletions were identified on Yq using 
FISH, polymerase chain reaction, and direct sequencing with a 
literature review.
Case report 
A 15-year-old boy was referred to the pediatric endocrinology 
service due to his persistent gynecomastia over 2 years and 
short stature. He was the first boy of  two brothers from 
nonconsanguineous Korean parents. His birth weight was 2,800 
g after a full-term delivery. He has been followed up in pediatric 
psychology because of mild intellectual disability (intelligence 
quotient, 71). His height, weight, and body mass index were 
157.4 cm (5th–10th percentile), 62.1 kg (50th–75th percentile), 
and 25.06 kg/m2 (85th–90th percentile), respectively. His 
father's height was 174 cm, his mother's height was 159 cm, and 
the midparental height was 173 cm. His growth velocity was 
4 cm/yr, and his parents reported an indistinct pubertal spurt. 
He manifested nontender bilateral breast enlargement. A small 
phallus was noticed, and the bilateral testes were palpated. The 
volume of each was measured as 6 mL. He was at the pubertal 
stages of developing the breasts of Tanner III and the pubic 
hair of Tanner III. A knuckle-dimple sign was shown on his 
left hand, and the fourth toe of his left foot was remarkably 
short. A basal hormonal study showed elevated estradiol and 
follicle-stimulating hormone (FSH) levels, and his testosterone 
(T) concentration was within the normal range (Table 2). The 
normal pubertal status of luteinizing hormone (LH) responses 
was recognized, however, an increased basal FSH level was 
revealed during a provocation test (Table 3).
Radiographs showed short fourth and fifth metacarpal and 
fourth metatarsal bones. His bone age was 15 years old by the 
Greulich and Pyle method at a chronological age of 15 years 
(Fig. 1). An abdominopelvic ultrasound revealed no ovary-
like structure or uterus and normal kidneys. Normal testes and 
a varicocele in the left testis were demonstrated; however, the 
4-year-followed testicular volume decreased to 3.8 mL and 3.9 
mL in each testis according to testicular ultrasound. The sella 
magnetic resonance imaging results was normal.
1. Cytogenetic and FISH analysis
Phytohemagglutinin-treated peripheral blood lymphocytes 
were prepared and cells were cultured, and then harvested after 
72 hours following standard protocol. Giemsa dye mixture was 
used for conventional G-bands by trypsin using Giemsa (GTG) 
Table 1. Summary of previous reports of non-mosaic 46,X,+mar in boys
Study Age Karyotype Comorbidities Conclusion
Hayashi et al.2) 1 yr 46,X,+mar Abnormal external genitalia, hypospadias SRY+, 46,X,der(9p)
Calzolari et al.4) 11 yr 46,X,+mar Obesity, short stature (<10p), bilateral cryptorchidism, 
  coarctation of the aorta
SRY+, 46,X,del(Y)(p11.3–q11.21)
Graham and Bacino5) 10 yr 10 mo 46,X,+mar Short stature (<5p), developmental delay, bilateral 
  cryptorchidism, bilateral hearing loss, webbed neck, 
  low posterior hairline, mild brachydactyly, short 4th, 
  and 5th metatarsals, murmur
SRY+, 46,X,der(Y)del(Y)(p11.23)del(Y)
(q11.23)
Fig. 1. Radiographs showed short fourth and fifth metacarpal bones in the left 
hand and fourth metatarsal bone in the left foot (arrows).
Table 2. Hormonal characteristics of the patient
Variable Baseline Reference range
T3 (ng/dL) 168 78–181
Free T4 (ng/dL) 1.21 0.80–1.48
TSH (μIU/mL) 2.88 0.35–4.2
PTH (pg/mL) 41.2 10–55
Testosterone (ng/dL) 249.2 100–320
Estradiol (pg/dL) 14.92 0.5–2.5
LH (mIU/mL) 3.19 0.2–5.0
FSH (mIU/mL) 18.4 1.2–5.8
Prolactin (ng/mL) 10.4 2–18
T3, triiodotyronine; T4, thyroxine; TSH, thyroid stimulation 
hormone; PTH, parathyroid stimulation hormone; LH, leutenizing 
hormone; FSH, follicular stimulating hormone.
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technique. Then metaphase cells were analyzed to reported as 
46,X,+mar by the International System for Human Cytogenetic 
Nomenclature (ISCN 2009) (Fig. 2A). The karyotypes of family 
members were normal.
FISH analysis was conducted to identify the existence of 
Y chromosome on marker chromosome. AneuVysion Test 
Kit (Abbott Laboratories, Abbott Park, IL, USA) was utilized 
according to manufacturer's instruction. Vysis CEP Y, orange-
colored probes for DYZ3 corresponding centromere of the 
Y chromosome (Yp11.1–q11.1) and Vysis CEP X, green-
colored probes for DXZ1 corresponding centromere of the X 
chromosome (Xp11.1–q11.1) were hybridized to metaphase 
cells. Figures of images were obtained with a CytoVision 
platform (Leica Biosystems, Richmond, IL, USA). FISH study 
revealed that the marker chromosome in this case includes the 
centromere of the Y chromosome of all 150 cells in metaphase 
(Fig. 2B). 
2. Polymerase chain reaction and Y-specific STS
Genomic DNA of patient was extracted from peripheral 
blood samples. QIAamp DNA Blood Midi Kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s protocol. 
Extracted DNA were stored at -70℃ until experiment. Twenty-
five Y chromosome specific sequences located in both arms of 
the Y chromosome were used to detect cryptic Y chromosome 
material by polymerase chain reaction (PCR) analysis. All 
primers were designed by Primer3 program (http://bioinfo.
ut.ee/primer3/). The Taq polymerase reagents were purchased 
from Takara (Takara Bio, Otsu, Japan). PCR was performed with 
20 ml of PCR amplification reaction mixture containing 10X 
Ex Taq DNA polymerase buffer with 2.5 mM of each dNTP, 0.5 
mM of each primer, 500 ng of DNA, and 2.5 units of Taq DNA 
polymerase. 
Amplifications were conducted in duplicate with the PTC-
200 thermocycler (MJ Research) with the following profile: 
94℃ for 5 minutes, 35 cycles of 95℃ for 30 seconds, 50℃ for 
(A) (B)
Fig. 2. (A) The karyotype of the present case was identified as 46, X, +mar (arrow indicates marker chromosome). 
Centromere of the Y chromosome was confirmed on the marker chromosome for all 150 cells in metaphase via 
fluorescence in situ hybridization. (B) The green probe is for DXZ1 (Xp11.1–q11.1), and the orange probe is for DYZ3 
(Yp11.1–q11.1). DXZ and DYZ, D (DNA), Y (Y chromosome), X (X chromosome), Z (Z-repetitive copy DNA).
Table 3. Provocation test of the patient
Provocation test
Time
0 Min 30 Min 60 Min 90 Min 120 Min 0 Day 3 Days
Combined pituitary function test
  GH* (ng/dL) 0.46 <0.1 <0.1 5.7 5.1 - -
  GH† (ng/dL) 0.31 6.6 6.0 2.7 2.4 - -
  Glucose (mg/dL) 91 35 102 148 143 - -
  LH (mIU/mL) 3.67 37.08 23.15 18.94 15.56 - -
  FSH (mIU/mL) 13.6 44.4 35.4 34.4 33.2 - -
  ACTH (pg/ mL) 13.9 294.7 103.5 27.24 10.75 - -
  Cortisol (μg/dL) 5.3 32.8 34.1 29.2 21.7 - -
  TSH (μIU/mL) 3.29 15.26 8.8 7.06 5.81 - -
hCG stimulation test
  Testosterone (ng/dL) - - - - - 344.6 808.3
  DHT (ng/dL) - - - - - 36 64
  Testosterone/DHT - - - - - 9.57 12.63
GH, growth hormone; LH, leutenizing hormone; FSH, follicular stimulating hormone; ACTH, adrenocorticotropic hormone; TSH, thyroid 
stimulation hormone; hCG, human chorionic gonadotropin; DHT, dihydrotestosterone.
*GH induced with L­dopa. †GH induced with insulin.
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30 seconds, 72℃ for 30 seconds and final extension at 72℃ 
for 10 minutes. One negative and positive sample was loaded 
to compare with the expression patterns of the patient. One 
percent (1%) agarose gels were used to separate PCR products 
by electrophoresis.
Seven of Y-specific sequence-tagged site (STS): SRY, proximal 
border of  pseudoautosomal region of  Y (PABY), DYS14, 
amelogenin sequence of  Y (AMGY), sY57, DYS265 were 
confirmed on Yp and centromere (DYZ3) was verified using 
PCR and direct sequencing (not shown). Azoospermia factor 
(AZF) b region was partially deleted, and AZFa and AZFc 
were completely deleted. Two STS probes of sY143 and Y 
chromosome RNA recognition motif (YRRM) in AZFb showed 
positive signals corresponding to Yq11.223 (Fig. 3).
Therefore, the karyotype of this case was interpreted as 
46,X,der(Y)del(Y)(q11.21q11.222) del(Y)(q11.23qter).
3. Ethics statement
This study was approved by the Institutional Review Board 
(IRB) of  Yonsei University Severance Hospital (approval 
number: 4-2017-0977). Informed consent was waived by the 
IRB.
Discussion
Physiologic pubertal gynecomastia is common in adolescents 
at 13 or 14 years of age and generally manifests a unilateral or 
bilateral, transiently tender, rubbery or firm mass in a concentric 
location. Most physiologic pubertal gynecomastia regresses 
within 1–2 years9). A cohort study reported that if it is persistent 
beyond 2 years and prominent over B3, endocrine evaluation 
should be considered10). The persistent, prominent gynecomastia 
group has underlying causes, including increased aromatase 
activity, adrenal or testicular neoplasm, partial androgen 
insensitivity syndrome, and a disorder of sex differentiation 
(DSD), such as Klinefelter syndrome, 46,XX, testicular (SRY+)-
associated hypogonadism, or genital abnormalities11). When 
gonadotropin levels are elevated, the karyotype should be 
examined9). Therefore, the present case manifested clinical 
features suggesting DSD, such as a small phallus and small 
testicles, so karyotyping was performed. Interestingly, his 
karyotype of 46,X,+mar was identified as 46,X,der(Y).ish der(Y)
(DAZ3+). In addition, deletions of Yq and preserved SRY were 
verified by PCR. 
This present case carrying 46,X,+mar showed obesity, short 
stature, small testes, short fourth, and fifth metacarpals and 
metatarsal bones. These are similar clinical manifestations to 
those in previous reports (Table 1). 46,X,del(Yq) is associated 
with tubular hyalinization, spermatogenic maturation arrest, 
Sertoli cell-only syndrome (SCOS), and small testes with 
testicular lesion, and related comorbidities are short stature, 
intellectual disability, and gynecomastia12).
The short arm of the Y chromosome is subdivided into 
intervals 1 to 4A13), and SRY is a key factor for sex determination 
located on distal PABY of  Yp. Testis transcript Y1, testis 
transcript Y2, and AMGY are located on interval 3 of Yp11). In 
this case, the existence of SRY was confirmed by PCR, which 
explains his male phenotype. 
The long arm of the Y chromosome was subdivided into 
intervals 4B to 7. Polymorphism of the heterochromatin located 
in Yq12 at interval 7 is frequently observed; however, its function 
(A) (B)
Fig. 3. Schematic map of the microdeleted Ychromosome with loci investigated in the case (A) using polymerase chain reaction of 25 Y-specific sequence-tagged site (STS) 
markers and direct sequencing (not shown) (B). Sex-determining region Y (SRY) was preserved, but there were microdeletions of AZFa, AZFb, and AZFc, and a deletion 
of heterochromatin. (A) Deleted loci of Yq were displayed as (-) and bold characters indicate positive STS on the Y-derived marker chromosome. PABY, proximal border of 
the pseudoautosomal region of Y; AMGY, amelogenin sequence of Y; YRRM, Y chromosome RNA recognition motif; AZF, azoospermia factor; DYZ and DYS, D (DNA), Y (Y 
chromosome), Z (Z-repetitive copy DNA), S (segment, and the number indicates published order of specific cloned DNA sequence).
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is inert. In contrast, the Yq11 region is known to influence 
growth control, teeth development, the anti-Turner effect, and 
fertility13,14). Y-specific growth control regions (GCY) are related 
to short stature15) and located in interval 5 within a narrow 
range immediately below the centromere. GCY is speculated to 
control growth hormone and the insulin-like growth factor-I 
receptor or postreceptor pathway15). 
Various combinations of  manifestations, such as short 
stature, a webbed neck, cubitus valgus, short fourth and 
fifth metacarpals, a low posterior hairline, pigmented nevi, 
and gynecomastia, are related to microdeletions of the Yq 
chromosome in some cases4,5,14). In the present case, the male 
patient showed skeletal deformities of the hand and foot, short 
stature, and gynecomastia with no DNA loci among sY82, 
sY83, sY84, DYS7, and DYS280 in interval 5 on proximal Yq. 
These findings are consistent with previous reports regarding 
the correlation between proximal Yq deletion and skeletal 
deformities16). Many reports of Yq microdeletions have been 
performed in adult age during the evaluation of fertility; 
however, pubertal gynecomastia is first described in this case.
Structural microdeletions of the Y chromosome are found 
in 7.7% of infertile Korean adults and vary between 5.7%–21% 
worldwide3). In addition, Yq microdeletion can be attributable to 
varicoceles, cryptorchidism, and infertility as well as intellectual 
disability12). In this case, the patient had a varicocele in 1 testis 
and was suffering from mild intellectual disability.
The AZF within the Yq region is related to infertility and 
subdivided into AZFa, AZFb, and AZFc. Deleted AZF is associa-
ted with oligospermia or severe azoospermia. The deletion of 
the AZFc region occurs most frequently, followed by AZFb, 
whereas the complete deletion of AZFa is rarely discovered in 
male infertility. In this case, YRRM and DYS231 (sY143) were 
detected from several loci of Yq11.223 in the AZFb region. 
This is consistent with partial deletion of AZFb in interval 6. 
However, no loci were identified in the AZFa and AZFc regions. 
In addition, the complete deletion of AZFa causes small testes 
and SCOS. SCOS is a condition of spermatogenic failure in 
seminiferous tubules lined with only Sertoli cells confirmed 
by testicular biopsy, and azoospermia should be accompanied 
by semen analysis. In general, SCOS is diagnosed in adults 
while examining sterility. Typical laboratory findings are 
normal T, mainly normal or elevated LH, decreased inhibin B, 
and increased FSH 2–3 times3). Inhibin B and FSH are useful 
predictors or markers of Sertoli cell function during a follow-up 
period17). In this case, testicular biopsy and sperm analysis were 
not performed due to the patient's young age. However, 4 years 
later, both testicular volumes were remarkably reduced from 
6 mL to less than 4 mL. Hormonal concentrations of T were 
found within the normal range as well as 4 years later, the FSH 
level was markedly elevated, and complete deletion of AZFa 
was confirmed by PCR. These findings suggest the possibility 
of SCOS. Even though men are presumed with SCOS, sperm 
retrieval could be possible via testicular sperm extraction 
(TESE) or micro-TESE, which appear to be recommendable 
in such cases18). Moreover, several studies have been reported 
that it is possible to identify sperm cells in TESE in 57% of 
partial deletion of AZFb, and 43% of partial deletion of AZFb-c, 
but, in 7% of complete deletion of AZFb and 3% of complete 
deletion of AZFb-c19). Judging from the partial deletion of AZFb, 
although this patient received neither sperm analysis nor TESE 
yet, the possibility of sperm retrieval remains to be present. 
Therefore, it is clinically important to verify the microdeletions 
of Yq to determine the treatment and prognosis.
In conclusion, when there is gynecomastia accompanied by 
raised gonadotropin levels, karyotyping should be performed. 
Furthermore, when a conventional banding technique 
demonstrates a marker chromosome instead of a normal sex 
chromosome, it is necessary to conduct full endocrine evalua-
tions that include cytogenetic and DNA molecular analyses 
to investigate the existence of a sex chromosome or SRY 
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